CINECA IRIS Institutional Research Information System

IUDICE, ALFONSO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.564
AS - Asia 3.515
EU - Europa 2.608
SA - Sud America 458
AF - Africa 154
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.325
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.295
CN - Cina 1.152
SG - Singapore 1.010
IT - Italia 888
HK - Hong Kong 520
BR - Brasile 374
SE - Svezia 345
DE - Germania 305
VN - Vietnam 275
BG - Bulgaria 241
CA - Canada 217
TR - Turchia 174
GB - Regno Unito 155
UA - Ucraina 132
FI - Finlandia 130
FR - Francia 117
RU - Federazione Russa 103
IN - India 92
KR - Corea 88
CI - Costa d'Avorio 81
CH - Svizzera 58
JP - Giappone 53
MX - Messico 33
AR - Argentina 31
AT - Austria 31
PL - Polonia 30
IQ - Iraq 29
SN - Senegal 23
NZ - Nuova Zelanda 19
BD - Bangladesh 16
ID - Indonesia 15
NL - Olanda 15
ZA - Sudafrica 15
BE - Belgio 14
EC - Ecuador 14
CO - Colombia 11
SA - Arabia Saudita 11
CL - Cile 9
ES - Italia 9
VE - Venezuela 9
PK - Pakistan 8
UZ - Uzbekistan 8
NG - Nigeria 7
AU - Australia 6
IR - Iran 6
JO - Giordania 6
LT - Lituania 6
MY - Malesia 6
TW - Taiwan 6
EG - Egitto 5
HU - Ungheria 5
IL - Israele 5
KZ - Kazakistan 5
MA - Marocco 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
PA - Panama 4
PT - Portogallo 4
TN - Tunisia 4
AL - Albania 3
DZ - Algeria 3
GT - Guatemala 3
KE - Kenya 3
LB - Libano 3
ME - Montenegro 3
NP - Nepal 3
OM - Oman 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
BB - Barbados 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
MN - Mongolia 2
PE - Perù 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BJ - Benin 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MW - Malawi 1
NO - Norvegia 1
PR - Porto Rico 1
Totale 14.318
Salva come PNG Salva come JPEG
Città #
Woodbridge 863
Ashburn 791
Singapore 567
Hong Kong 514
Ann Arbor 510
Santa Clara 491
Fairfield 476
Houston 436
Chandler 434
Shanghai 433
San Jose 336
Milan 330
Dallas 300
Sofia 241
Seattle 226
Beijing 219
Wilmington 188
Jacksonville 186
New York 175
Cambridge 173
Ottawa 173
Serra 149
Izmir 120
Boardman 111
Princeton 97
Nanjing 93
Lawrence 92
Seoul 88
Medford 87
Lauterbourg 82
Abidjan 81
Los Angeles 81
Hefei 79
Ho Chi Minh City 69
Des Moines 59
Florence 59
Bern 55
Tokyo 51
Munich 44
Hanoi 43
Istanbul 43
Buffalo 40
Dong Ket 39
Council Bluffs 34
Dearborn 34
Redwood City 34
Jüchen 33
Nanchang 32
Columbus 30
Warsaw 30
Frankfurt am Main 29
Redondo Beach 29
San Diego 29
São Paulo 29
Vienna 28
London 27
Orem 27
The Dalles 27
Rome 26
Helsinki 25
Ogden 24
Dakar 23
Norwalk 23
Washington 22
Changsha 21
Boulder 19
Baghdad 17
Düsseldorf 16
Kunming 16
Pune 16
Turku 16
Chennai 15
Bremen 14
Shenyang 14
Brussels 13
Christchurch 12
Hebei 12
Falls Church 11
Mexico 11
Nuremberg 11
Nürnberg 11
Rio de Janeiro 11
Montreal 10
Tianjin 10
Belo Horizonte 9
Hangzhou 9
Jiaxing 9
Mumbai 9
Amsterdam 8
Brasília 8
Chicago 8
Phoenix 8
Portsmouth 8
Toronto 8
Auburn Hills 7
Auckland 7
Denver 7
Guangzhou 7
Lagos 7
Manchester 7
Totale 10.721
Salva come PNG Salva come JPEG
Nome #
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery 365
SLEEP DISTURBANCES IN ELDERLY SUBJECTS: AN EPIDEMIOLOGICAL SURVEY IN AN ITALIAN DISTRICT 253
Daytime sleepiness in de novo untreated patients with epilepsy. 236
Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine 228
Controversial issues on EEG after sleep deprivation for the diagnosis of epilepsy 227
Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome. 220
Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial 219
A clinical and laboratory study evaluating the profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis 218
A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients 214
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 200
Insulinoma presenting as idiopathic hypersomnia 190
Effects of antiepileptic drugs on interictal epileptiform discharges in focal epilepsies: an update on current evidence 188
MDMA and seizures: a dangerous liaison? 187
Asymmetric scalp distribution of pattern visual evoked potentials during interictal phases in migraine 184
Long-term follow-up of 106 multiple sclerosis patients undergoing IFN-ß 1a or 1b therapy: predictive factors of thyroid disease development and duration 183
Impaired oxidative metabolism in exercising muscle from ALS patients. 183
Sustained wakefulness combined with blood alcohol legal concentrations: effects on car driving performance. 182
Clinical and demographic features of multiple sclerosis in an Italian register: a cross-sectional ecologic study 182
DAYTIME VIGILANCE AND QUALITY OF LIFE IN EPILEPTIC PATIENTS TREATED WITH VAGUS NERVE STIMULATION 182
Usefulness of a simple sleep-deprived EEG protocol for epilepsy diagnosis in de novo subjects. 182
Sleep disturbances in an elderly population: An epidemiological survey 179
Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. 179
Effect of lacosamide on sleep-wake cycle of adult patients with drug-resistant partial onset epilepsy 177
Plasmatic oxidative stress biomarkers in multiple sclerosis patients with different clinical course 177
Restless legs syndrome is a common finding in multiple sclerosis and correlates with pyramidal disability and cervical cord damage 175
Vagus Nerve Stimulation as a Treatment for Refractory Epilepsy: A 15-Year Experience in an Italian Tertiary -Care Epilepsy Center 175
Predictive factors of thyroid disease during sustained INF-ß therapy in 106 multiple sclerosis patients 174
Plasmatic oxidative stress biomarkers in multiple sclerosis: Relation with clinical and demographic characteristics. 174
A Clinical-EEG Study of Sleepiness and Psychological Symptoms in Pharmacoresistant Epilepsy Patients Treated with Lacosamide 172
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 170
The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial. 170
Very late onset multiple sclerosis likely associated with restless legs syndrome. A case report. 170
RIZATRIPTAN DOES NOT CHANGE CEREBRAL BLOOD FLOW VELOCITY DURING MIGRAINE ATTACKS 169
Multiple Sclerosis and Neurofibromatosis type1: case report 168
Profile of cytokine levels in relapsing remitting and secondary progressive multiple sclerosis: a clinical and laboratory study. 167
AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel. 166
Novel treatment options for epilepsy: focus on perampanel. 165
Alternative monotherapy or add-on therapy in patients with epilepsy whose seizures do not respond to the first monotherapy: an Italian multicenter prospective observational study. 165
A FUNCTIONAL POLYMORPHISM IN THE SCN1A GENE DOES NOT INFLUENCE ANTIEPILEPTIC DRUG RESPONSIVENESS IN ITALIAN PATIENTS WITH FOCAL EPILEPSY 162
Health-related quality of life in epilepsy: findings obtained with a new Italian instrument 161
LORMETAZEPAM EFFECTS ON DAYTIME VIGILANCE PSYCHOMOTOR PERFORMANCE AND SIMULATED DRIVING IN YOUNG ADULT HEALTHY VOLUNTEERS 157
PSYCHOMOTOR PERFORMANCE IN HEALTHY YOUNG ADULT VOLUNTEERS RECEIVING LORMETAZEPAN AND PLACEBO 155
DAYTIME SLEEPINESS IN EPILEPSY PATIENTS RECEIVING TOPIRAMATE MONOTHERAPY 153
Relevance of clinical context in the diagnostic-therapeutic approach to status epilepticus 153
Effects of Alzheimer's disease and mild cognitive impairment on driving ability: a controlled clinical study by simulated driving test 153
Evaluation of daytime vigilance levels and quality of life in subjects with refractory epilepsy treated with vagus nerve stimulation 151
Crisi epilettiche ed altre manifestazioni accompagnate da convulsività. 149
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. 149
Malattie neurologiche in gravidanza 147
I farmaci inibitori delle colinesterasi nel trattamento dei disturbi psichici e comportamentali nella malattia di Azheimer: focus su galantamina 145
A new symtomatic form of restless legs syndrome associated with multiple sclerosis 145
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 145
A CLINAL-EEG STUDY IN PHARMACORESISTANT EPILEPSY PATIENTS TREATED WITH LACOSAMIDE 145
Sleep disturbance in a population of epileptic patients 144
DREAM RECALL FREQUENCY IN EPILEPSY PATIENTS WITH PARTIAL AND GENERALIZED SEIZURES 143
Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy. 143
DAYTIME SLEEPINESS IN MID AND MODERATE ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH COGNITIVE IMPAIRMENT 138
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study 137
EFFECTS OF PROLONGED WAKEFULNESS COMBINED WITH ALCOHOL AND HANDS-FREE CELL PHONE DIVIDED ATTENTION TASKS ON SIMULATED DRIVING 136
Relation between cerebrospinal fluid oxidative stress biomarkers and intrathecal Ig synthesis in multiple sclerosis 136
Analysis of RR variability in drug-resistant epilepsy patients chronically treated with vagus nerve stimulation 135
PLASMATIC AND CEREBROSPINAL FLUID OXIDATIVE STRESS BIOMARKERS IN ACUTE AND CHRONIC POLYRADICULONEUROPATHIES 135
Complicanze gastrointestinali in pazienti neurologici trattati con glucocorticoidi: terapia con gli inibitori di pompa protonica 133
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports 133
Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis 133
Effetto sulla funzione di sensibilità al contrasto del vigabatrin in pazienti con epilessia 130
Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors 128
SWALLOWING REFLEX EPILEPSY: COULD ORAL THERAPY REPRESENT A PROBLEM? 127
Visual contrast sensitivity in Carbamazepine-resistant epileptic patients receiving Vigabatrin as add-on therapy 127
RELEVANCE OF COGNITIVE DETERIORATION IN EARLY RELAPSING-REMITTING MS: A 3-YEAR FOLLOW-UP STUDY 126
Le pseudocrisi epilettiche 124
Diagnosi e terapia della malattia di Parkinson 124
DREAM RECALL FREQUENCY IN EPILEPSY PATIENTS WITH PARTIAL AND GENERALIZED EPILEPSY: A DREAM DIARY STUDY 124
Fatigue and sleepiness in multiple sclerosis 121
ROLE OF A STANDARDIZED PARTIAL SLEEP-DEPRIVED EEG PROTOCOL IN THE DIAGNOSIS OF EPILEPSY, AND ITS CORRELATION TO CLINICAL AND NEUROIMAGING DATA 121
PHARMACOLOGICAL PROPHYLAXIS OF POST-TRAUMAITC EPILPSY 121
EEG in veglia e in sonno nella diagnosi di epilessia del lobo temporale 120
Paralisi facciale di Bell 111
SHOULD ANTI-EPILEPTIC DRUGS BE USED FOR PREVENTING SEIZURES AFTER ACUTE TRAUMATIC BRAIN INJURES? 108
Appropriate use of generic and branded antiseizure medications in epilepsy: Updated recommendations from the Italian League Against Epilepsy (LICE) 108
Aspetti psicopatologici in pazienti con pseudocrisi 106
Mismatch negativity analysis in drug-resistant epileptic patients implanted with vagus nerve stimulator 106
Funzioni neurologiche centrali e nervi cranici 105
CITALOPRAM AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY 104
L'ipersonnia iatrogena in neurologia 103
CIRCULATING LEVELS OF ALLOPREGNANOLONE IN WOMEN WITH PARTIAL EPILEPSY IN THE POSTCRITICAL PHASE 102
Sclerosi multipla, insieme fra speranze e limiti 101
I disturbi dell’umore nelle patologie neurologiche: dalla neurobiologia alla clinica 98
SECOND GENERATION ANTIHISTAMINE IN THE TRETMENT OF SESONAL ALLERGIC RHINITIS DUE TO PARIETARIA AND CYPRESS POLLEN 93
Sudden Death in Epilepsy: Two Case Reports 90
MITOCHONDRIAL DNA REARRANGEMENTS IN YOUNG ONSET PARKINSONISM 88
Driving ability in Alzheimer’s disease and mild cognitive impairment: a simulated driving study 88
Malattia di Azheimer e galantamina: profilo di efficacia derivante dalle revisioni sistematiche 88
EPIDEMIOLOGY OF MYOTONIC DYSTROPHY IN ITALY 69
null 48
Totale 14.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.003 23 70 26 76 196 130 30 63 36 21 63 269
2022/20231.252 137 147 77 114 142 167 4 96 260 5 94 9
2023/20241.142 147 162 158 82 169 243 26 13 19 13 33 77
2024/20253.109 7 121 10 127 384 323 428 146 308 394 320 541
2025/20262.801 234 400 294 190 309 282 433 114 155 260 98 32
2026/202714 14 0 0 0 0 0 0 0 0 0 0 0
Totale 14.440